The aim of this study was to compare pre-operative and post-operative voiding parameters following insertion of the MONARC transobturator tape (TOT), for treating @entity1 with urodynamic stress incontinence. This prospective observational study was conducted at a tertiary referral urogynaecology unit, in North Queensland, involving 83 @entity1 who were prospectively assessed pre-operatively and at 6-8 weeks following the procedure. Information collected included @entity1 demographics, concomitant surgery, pre-operative and post-operative symptomatology (using validated questionnaires), and pre-operative and post-operative urodynamic parameters. Parameters used to assess voiding function included symptoms of voiding difficulty (incomplete emptying and irritative symptoms) as well as objective parameters including maximum flow rate (Qmax), adjusted maximum flow rate (Qmaxadj) using the Liverpool nomogram (LN), maximal urethral pressure, and post-void residual (PVR). Pre-operative average Qmax was 23.7 ml/s compared to 21.1 ml/s post-operatively (p=0.064). When the Qmax was adjusted for voided volume using the LN, Qmaxadj was seen to decrease significantly from 26 ml/s to 18 ml/s (p<0.05). @entity1 with PVR>50 ml did not differ significantly pre-operatively and post-operatively, 5/83(6%) vs 7/83 (8.4%) (p=0.75). The number of @entity1 with a flow rate <10th centile on LN was 22 (26.5%) pre-operatively vs 29 (34.9%) post-operatively (p=0.21). One (1.2%) post-operatively had @entity409 diagnosed by an abnormal voiding pattern (p=0.728), which was not statistically significant. Objective @entity409 as determined by adjusted flow rates <10th centile LN and >50 ml PVR was seen in four @entity1 (4.8%). Adjusted free flow rates are significantly reduced following insertion of the MONARC TOT, as are some symptoms related to @entity409 . Despite this, satisfaction rates remain high with observed @entity409 or objective measures of @entity409 showing no statistical change in the short term. Long-term follow-up is planned at 1 year.

Does the MONARC transobturator suburethral sling cause XXXX ? A prospective study.

@entity1 :: ('9606', 'Species') :: ['women', 'Women', 'patient'] @entity409 :: ('MESH:D008107', 'Disease') :: ['voiding dysfunction']
@entity409 :: (MESH:D008107,Disease) :: ['post-operative voiding dysfunction']
